Eosinophil granole proteins as indicators of inflammatory bowel disorders
US5928883A · kind A · utility
5Cited by
8References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 12, 1997 |
| Grant date | Jul 27, 1999 |
| Priority date | — |
| Expiry date | Nov 12, 2017 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/2525
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A diagnostic method is provided for inflammatory bowel disorders (IBD), based on the relative levels of eosinophil granule proteins in physiological samples obtained from the GI tract of mammals suspected of having an IBD.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.